Connect with us

Technology

E-Health Now CEO Kelly Xu won 2024 Forbes China Science and Technology Innovation Figures Award

Published

on

BEIJING, April 28, 2025 /PRNewswire/ — The Global Science and Technology Innovation Conference and the “2024 Forbes China Science and Technology Innovation Figures” Awards Ceremony, jointly hosted by the Anhui Provincial People’s Government and the Global Science and Technology Innovation Alliance, was held grandly in Hefei, China in April 17-19, 2025. At this grand event focusing on “the Fission of the Sci-tech Innovation Ecosystem” and “Breaking Barriers in Globalization“, Kelly Xu, founder and CEO of E-Health Now, stood out from hundreds of candidates in China with her core innovative power and ecosystem-building capabilities in the life and health sector, and was awarded the “2024 Forbes China Science and Technology Innovation Figure”.

Leverage sci-tech innovation to redefine the boundaries of the medical service ecosystem

As one of Forbes China’s most influential rankings, the “Science and Technology Innovation Figures” list always focuses on pioneers who drive industrial transformation through technological innovation and model innovation. The selection process lasted for nearly a year, and the candidates were evaluated comprehensively based on multiple core indicators such as technological research and development capabilities, commercialization effectiveness, and industry ecosystem construction capabilities. Kelly Xu’s award is due to her leadership of E-Health Now in building a three-dimensional innovation system of “Technology + Scenario + Ecosystem” in the field of medical and health services:

Resource Integration & Service Enhancement: Leveraging partnerships with nearly 10,000 top-tier hospitals worldwide, along with proprietary digital healthcare platforms (including Internet hospitals and pharmacies), we have launched over 100 online and offline medical service products. This enables a seamless smart health management ecosystem, transcending traditional time and space constraints in healthcare delivery — ensuring broader access to premium medical resources;

In-depth application of AI technology: independently developed multiple intelligent tools such as AI general practitioner, doctor assistant, precise medical triage, traditional Chinese medicine, etc. Through big data analysis and intelligent diagnostic assistance, achieve industry breakthroughs in improving healthcare management operational service efficiency by 50-80% and doubling user health management coverage; using AI intelligent agent Dr. Hua as its core figure, integrating personalized AI and real healthcare services to achieve a closed loop from virtual advice to real-world ground breaking medical service experiences.

Business model innovation: Empowering institutional clients such as healthcare, insurance, and banking through the B2B2C model, serving tens of millions of end users, effectively addressing industry pain points such as lack of loyalty, fierce competition in product innovation and other challenges.

From deep technological cultivation to ecosystem Co-building, decoding the scientific and technological innovation genes of E-Health Now

Kelly Xu’s scientific and technological innovation practice has always been centered on “bringing technology services back to humanity”. Under her leadership, E-Health Now has established a closed-loop innovation model of “Resource integration – Technological empowerment – Scenario implementation – Value feedback”: on the one hand, it has deepened its research and development efforts in AI medical technology, and has accumulated more than 30 software copyrights and invention patents. Its “Precision Medical Analysis Algorithm” and “Haohai Traditional Chinese Medicine Consultation Text Generation Algorithm” have successfully passed the national level deep synthesis service algorithm filing; On the other hand, adhering to the principle of “serving the people”, customized medical service solutions are launched for health insurance clients of domestic and international insurers, community hospitals, Southeast Asian cross-border medical care, overseas Chinese remote medical care, overseas student health management and other segmented scenarios, allowing AI technology to truly serve real medical needs.

Promote the development of global scientific and technological innovation, and embark on a new journey of intelligent healthcare

This award is Kelly Xu’s second appearance on the industry list after being listed as a “Forbes China Emerging Innovator and Entrepreneur”, and also marks a new starting point for E-Health Now to move from “Chinese innovation” to “global innovation stage”. Facing with the opportunity of global healthcare transformation, Kelly Xu said that E-Health Now will accelerate the dual wheel drive of “technology going global” and “ecological co construction”: in Singapore and Southeast Asian markets, empower local hospitals with AI technology for digital upgrading, establish cross-border medical service networks, and improve regional service quality and efficiency. At the same time, the company plans to cooperate with leading medical device manufacturers in China and insurance institutions in Southeast Asia to provide overseas insurance companies with value-added medical critical illness insurance services, covering remote consultations, accompanying consultations, global specialty drug search, etc., allowing Southeast Asian critical illness patients to enjoy efficient and professional cross-border medical services in China.

Industry Impact: A Dual Breakthrough from Business Success to Social Value

Kelly Xu’s path of scientific and technological innovation not only creates commercial value for enterprises, but also demonstrates the social responsibility of technology companies. Through its “AI+Healthcare Management” service model, E-Health Now is empowering grassroots medical institutions to improve human productivity and diagnostic accuracy, reducing employee health management costs for enterprise customers. Its “one-stop artificial intelligence medical and health service platform” has served over 35 million end users. These practices have proven when technological innovation is deeply integrated with people’s livelihood needs, it can not only foster to new business forms, but also become the “golden key” to solving social problems.

Being awarded for the Forbes Science and Technology Innovation List this time is a recognition of Kelly Xu’s years of deep cultivation in healthcare technology, and also a showcase of China’s scientific and technological innovation power on the global stage. E-Health Now’s mission is to “enable everyone to enjoy 100 year of healthy life” and its vision is to “become a global leader in intelligent healthcare”. Through technological and service innovation and ecological reconstruction, it is becoming a “digital bridge” connecting global medical resources. In the future, with technological iteration and global rollout, E-Health Now will contribute more “Chinese wisdom” to human health, promoting the transformation of intelligent healthcare from vision to reality.

Company Name: E-Health Now Health Technology (Beijing) Co., Ltd
Contact Person: Ms. Luo
Email: marketing@ehealthnow.cn 
Website: www.huameihaolian.com 
Telephone: +8615801167074

View original content:https://www.prnewswire.com/apac/news-releases/e-health-now-ceo-kelly-xu-won-2024-forbes-china-science-and-technology-innovation-figures-award-302440454.html

SOURCE E-Health Now Health Technology (Beijing) Co., Ltd

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Shareholder Increases Interest in Baylin Technologies

Published

on

By

TORONTO, June 24, 2026 /CNW/ – Mr. Jeffrey C. Royer, Chairman of the Board of Baylin Technologies Inc. (the “Company”), announced that 2385796 Ontario Inc. (“238”) has entered into agreements to acquire an aggregate of an additional 17,139,616 common shares (“Common Shares”) in the Company.

On June 24, 2026, 238 entered into an exchange agreement with the Company pursuant to which the Company has agreed to exchange all of its $3,950,000 outstanding 10% Cumulative Redeemable Retractable Series A and Series B Preferred Shares held by 238, together with accrued and unpaid dividends thereon in the amount of $594,297.41, for an aggregate of 16,171,876 Common Shares, issued on a private placement basis at $0.281 per Common Share, plus a cash payment of approximately $0.25 in lieu of fractional shares (the “Exchange Transaction”).

Separately, also on June 24, 2026, 238 entered into a private agreement with a third party to acquire an additional 967,740 Common Shares at a price of $0.335 per Common Share (the “Private Agreement Transaction” and, together with the Exchange Transaction, the “Transactions”).

The aggregate 17,139,616 Common Shares acquired by 238 pursuant to the Transactions represent approximately 6.94% of the 246,933,341 Common Shares outstanding before giving effect to the Transactions.

Prior to giving effect to the Transactions, Mr. Royer exercised control and direction over approximately 50.3% of the outstanding Common Shares. After giving effect to the Transactions, 238 will hold an aggregate 135,896,242 Common Shares, representing approximately 51.7% of the 263,105,217 Common Shares that will be outstanding after giving effect to the Exchange Transaction. An Associate of Mr. Royer holds an additional 5,496,900 Common Shares. Mr. Royer exercises exclusive control and direction over the Common Shares held by 238 and by the Associate. Together, after giving effect to the Transactions, the Associate and 238 hold an aggregate of 141,393,142 Common Shares, representing approximately 53.7% of the Common Shares outstanding.

The Common Shares are being acquired for investment purposes. Mr. Royer may direct the purchase of additional Common Shares or other securities of the Company or direct the sale of Common Shares or other securities of the Company, in each case, based on market and other conditions or other circumstances.

A copy of the early warning report required by National Instrument 62-103 – The Early Warning System and Related Take-Over Bid and Insider Reporting Issues incorporating this and other information will be available under the Company’s issuer profile on SEDAR+ at www.sedarplus.ca and by contacting Kelly Myles, Marketing and Communications Director at the Company, at Kelly.myles@baylintech.com.

SOURCE Baylin Technologies Inc.

Continue Reading

Technology

Cold Chain Packaging Market Size to Reach USD 93.1 Billion by 2033, Driven by Biopharmaceutical Expansion, E-commerce Growth, and Rising Demand for Temperature-Sensitive Logistics

Published

on

By

Global market projected to grow at a CAGR of 13.5% from 2026 to 2033 as pharmaceutical, food, and healthcare industries increasingly rely on advanced cold chain packaging solutions

SAN FRANCISCO, June 24, 2026 /PRNewswire/ — The global cold chain packaging market is poised for significant expansion, with increasing demand from pharmaceutical manufacturers, healthcare providers, food distributors, and e-commerce platforms fueling long-term growth. According to the latest industry analysis by Grand View Research, the global cold chain packaging market was valued at USD 33.7 billion in 2025 and is expected to reach USD 93.1 billion by 2033, expanding at a CAGR of 13.5% from 2026 to 2033.

The market’s growth trajectory reflects the critical role cold chain packaging plays in protecting temperature-sensitive products throughout storage, transportation, and distribution. As global supply chains become increasingly complex and consumers demand faster delivery of perishable goods, businesses are investing heavily in advanced insulated packaging technologies capable of maintaining product integrity across extended transit durations.

Rising Biopharmaceutical Demand Accelerating Market Growth

One of the primary factors driving industry expansion is the rapid growth of biopharmaceuticals, vaccines, biologics, insulin, and specialty medicines. These products require precise temperature control throughout the supply chain to maintain efficacy and regulatory compliance.

The increasing adoption of personalized medicine, cell and gene therapies, and biologic drug formulations has intensified the need for validated cold chain packaging systems. Pharmaceutical companies are prioritizing advanced thermal packaging solutions that minimize temperature excursions while supporting global distribution networks.

Stringent compliance requirements imposed by regulatory authorities worldwide are further encouraging pharmaceutical manufacturers and logistics providers to deploy high-performance cold chain packaging technologies that ensure product safety and quality.

Expanding Global Food Supply Chains Create New Opportunities

Beyond healthcare applications, the cold chain packaging market continues to benefit from growing international trade in perishable food products. Fresh fruits, vegetables, dairy products, seafood, processed foods, and frozen meals increasingly rely on temperature-controlled transportation to preserve freshness and extend shelf life.

Changing consumer lifestyles and rising demand for year-round availability of fresh foods are strengthening the need for efficient cold chain infrastructure. As food manufacturers and retailers seek to reduce spoilage and food waste, investments in insulated containers, refrigerant systems, gel packs, and thermal packaging solutions continue to rise.

The emergence of modern retail channels and direct-to-consumer food delivery models is also supporting long-term market expansion, particularly in developing economies experiencing rapid urbanization and digital transformation.

Get Free Sample of this research report for more Insights

E-commerce and Last-Mile Delivery Reshaping Industry Dynamics

The continued growth of e-commerce grocery platforms, meal-kit providers, and online pharmaceutical delivery services has transformed cold chain logistics requirements.

Consumers increasingly expect fast and reliable delivery of temperature-sensitive products directly to their homes. This shift has created substantial demand for lightweight, cost-effective, and durable packaging solutions capable of maintaining required temperature ranges during last-mile transportation.

Industry participants are responding with innovations focused on enhanced insulation performance, reusable packaging formats, and real-time monitoring technologies that provide greater visibility across the supply chain.

As digital commerce continues to expand globally, cold chain packaging providers are expected to benefit from rising shipment volumes and increasing customer expectations regarding product quality upon delivery.

Sustainability and Material Innovation Driving Competitive Advantage

Environmental sustainability has emerged as a key strategic priority within the cold chain packaging industry. Companies are increasingly developing recyclable, reusable, and biodegradable packaging solutions to address growing environmental concerns and corporate sustainability commitments.

Advancements in fiber-based insulation materials, paper-derived thermal liners, and environmentally responsible refrigerants are enabling manufacturers to reduce environmental impact without compromising thermal performance.

Furthermore, innovations in phase change materials (PCMs), vacuum insulated panels (VIPs), and smart packaging systems are enhancing operational efficiency while helping organizations achieve sustainability objectives.

The integration of temperature-monitoring sensors and data-logging technologies is also improving supply chain transparency and enabling proactive risk management throughout transportation networks.

Segment Insights Highlight Emerging Growth Areas

By material, expanded polystyrene (EPS) dominated the market in 2025, accounting for more than 38.0% of total revenue. The segment’s strong position is attributed to its superior insulation capabilities, lightweight design, affordability, and widespread adoption across pharmaceutical and food logistics applications.

Meanwhile, the paper and paperboard segment is expected to register the fastest growth rate, expanding at a CAGR of 14.8% through 2033. Rising sustainability mandates and increasing demand for recyclable packaging alternatives are accelerating adoption across multiple industries.

From a product perspective, insulated containers accounted for more than 41.0% of market revenue in 2025. Their ability to provide reliable thermal protection for pharmaceuticals, biologics, and perishable food products continues to support widespread usage.

Vacuum insulated panels are anticipated to emerge as the fastest-growing product segment, registering a CAGR of 14.2% during the forecast period. Their superior thermal efficiency, lightweight construction, and extended temperature-hold capabilities make them increasingly attractive for high-value and long-duration shipments.

The pharmaceuticals segment is projected to grow at a CAGR of 16.0% through 2033, reflecting rising demand for temperature-controlled packaging solutions across global healthcare supply chains.

Browse more packaging Industry Research Reports

North America Maintains Market Leadership While Asia Pacific Gains Momentum

North America accounted for more than 32.0% of global market revenue in 2025, making it the largest regional market. The region benefits from a well-established pharmaceutical industry, advanced cold chain infrastructure, and strong demand for frozen and processed food products.

The United States remains a key growth engine due to ongoing investments in biologics manufacturing, vaccine distribution, and temperature-sensitive healthcare logistics.

At the same time, Asia Pacific is expected to emerge as the fastest-growing regional market over the forecast period. Expanding healthcare infrastructure, increasing pharmaceutical production, rising disposable incomes, and rapid growth in e-commerce food delivery services are creating substantial opportunities across major economies including China, India, Japan, and Southeast Asia.

Competitive Landscape

The cold chain packaging market remains moderately concentrated, with leading companies focusing on innovation, sustainability, thermal performance, and regulatory compliance to strengthen their competitive positions.

Major industry participants include Cold Chain Technologies, Cryopak, ThermoSafe, Dawsongroup, SOFRIGAM, CSafe, Peli BioThermal LLC, Sealed Air, CoolPac, Nordic Cold Chain Solutions, Inmark Global Holdings, Envirotainer, DGP Intelsius LLC, TemperPack, and Polar Tech Industries.

Strategic investments in reusable packaging systems, smart monitoring technologies, advanced insulation materials, and packaging-as-a-service business models are expected to shape future competition within the industry.

Market Outlook

As pharmaceutical innovation accelerates, global food trade expands, and e-commerce distribution networks continue evolving, cold chain packaging will remain a critical component of modern supply chains. The industry’s ability to deliver reliable temperature control while addressing sustainability challenges positions it for sustained growth throughout the forecast period.

With the market expected to nearly triple in value by 2033, companies that successfully combine thermal performance, regulatory compliance, digital monitoring capabilities, and environmentally responsible materials are likely to capture significant opportunities in the years ahead.

To learn more about growth opportunities in the Cold Chain Packaging Market, access the full report from Grand View Research

About Grand View Research
Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Explore Grand View Brainshare – Delivering value and creating impact for our clients through actionable business insights

Contact:
Michelle Thoras
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Web: https://www.grandviewresearch.com
Follow Us: LinkedIn | Twitter
Blog – https://globalindustryherald.com/

View original content to download multimedia:https://www.prnewswire.com/news-releases/cold-chain-packaging-market-size-to-reach-usd-93-1-billion-by-2033–driven-by-biopharmaceutical-expansion-e-commerce-growth-and-rising-demand-for-temperature-sensitive-logistics-302807886.html

SOURCE Grand View Research, Inc

Continue Reading

Technology

CDNetworks Launches New Solution to Accelerate and Secure AI Aggregation Platforms Worldwide

Published

on

By

Purpose-built to help emerging AI aggregation platforms reduce cross-region latency, manage traffic spikes, and protect APIs.

SINGAPORE, June 25, 2026 /PRNewswire/ — CDNetworks, the APAC-leading network to deliver edge as a service, today announced a new solution designed to help AI aggregation platforms deliver faster, more reliable, and more secure AI experiences to business users worldwide.

As enterprises adopt multiple AI models across business functions, AI aggregation platforms are emerging as a key access layer for model selection, task routing, and cost optimization. However, as these platforms scale across regions, they face growing pressure to maintain low-latency performance, handle unpredictable traffic spikes, and protect increasingly exposed AI model APIs.

CDNetworks’ new solution addresses these challenges by combining global acceleration with edge-native security. Built on CDNetworks’ global network of 3,000+ Points of Presence, the solution helps AI aggregation platforms deliver fast, stable, and secure AI interactions, regardless of where users, applications, or AI models are located.

The solution enables AI aggregation platforms to:

Improve global performance with intelligent routing, 3,000+ PoPs, and support for HTTP/2, HTTP/3, and WebSocket.Protect applications and APIs with edge-native WAAP capabilities, including DDoS protection, WAF, bot management, and API security.Simplify deployment and operations through a unified management console, real-time monitoring and analytics, and 24/7 expert support.

The solution is already delivering measurable results. In a recent deployment, a global AI aggregation platform using CDNetworks reduced global latency by 70% and origin bandwidth consumption by 60%, while maintaining continuous protection for its AI model APIs.

“AI aggregation platforms offer enterprises a flexible approach to working with multiple AI models. But their true potential will only be realized when they become a reliable part of the workflows where business decisions actually happen”, said Antony Li, APAC Head of Sales at CDNetworks. “By launching this new solution, CDNetworks is giving these platforms the infrastructure confidence to support AI interactions at scale.”

To learn more about CDNetworks’ solution for AI aggregation platforms, visit here.

About CDNetworks

As the APAC-leading network with over 3,000 global Points of Presence and more than 20 years of technology experience, CDNetworks delivers the fastest and most secure digital experiences to end users. Our diverse products and services include web performancemedia deliverycloud securityedge computingzero-trust security, and colocation services — all designed to spur business innovation.

To learn more, visit cdnetworks.com and follow us on LinkedIn.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/cdnetworks-launches-new-solution-to-accelerate-and-secure-ai-aggregation-platforms-worldwide-302808614.html

SOURCE CDNetworks

Continue Reading

Trending